Guzman R J, Lemarchand P, Crystal R G, Epstein S E, Finkel T
Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md. 20892.
Circ Res. 1993 Dec;73(6):1202-7. doi: 10.1161/01.res.73.6.1202.
Previous studies have established that gene transfer into myocardial cells in vivo is detectable after direct injection of plasmid DNA. Recently, adenovirus vectors have been shown to provide an efficient method for gene transfer into a wide range of tissues. Therefore, this study sought to assess the efficiency and stability of adenovirus-mediated gene transfer into myocardium and to compare this method with that using plasmid-based gene transfer techniques. Adult rats underwent myocardial injection via a subdiaphragmatic approach. Gene transfer efficiency was compared using direct injection of an adenovirus vector encoding for the marker gene beta-galactosidase (beta-gal), a control adenovirus vector encoding for the cystic fibrosis transmembrane conductance regulator gene, a plasmid encoding for beta-gal, or a control plasmid. Hearts infected with an adenovirus vector containing the beta-gal gene showed significantly increased beta-gal enzymatic activity compared with hearts injected with beta-gal plasmid. Histological examination revealed that cardiac myocytes were the target of adenovirus-mediated gene transfer. A time course of gene expression showed that beta-gal enzymatic activity peaked during the first week following injection. Adenovirus vectors provide an efficient but transient method for in vivo gene expression in myocardium.
先前的研究已经证实,在直接注射质粒DNA后,可检测到体内心肌细胞中的基因转移。最近,腺病毒载体已被证明是一种将基因高效转移到多种组织的有效方法。因此,本研究旨在评估腺病毒介导的基因转移到心肌中的效率和稳定性,并将该方法与基于质粒的基因转移技术进行比较。成年大鼠通过膈下途径进行心肌注射。使用直接注射编码标记基因β-半乳糖苷酶(β-gal)的腺病毒载体、编码囊性纤维化跨膜传导调节基因的对照腺病毒载体、编码β-gal的质粒或对照质粒来比较基因转移效率。与注射β-gal质粒的心脏相比,感染含有β-gal基因的腺病毒载体的心脏显示出显著增加的β-gal酶活性。组织学检查显示心肌细胞是腺病毒介导的基因转移的靶标。基因表达的时间进程表明,β-gal酶活性在注射后的第一周达到峰值。腺病毒载体为心肌中的体内基因表达提供了一种有效但短暂的方法。